Cardiology Wiki
Search
Ctrl
+
K
Cardiology Wiki
Search
Ctrl
+
K
wiki
concepts
AAV Gene Delivery
ACHD Anatomic–Physiologic (AP) Classification
ACMG Secondary Findings
Acute Limb Ischemia (ALI)
AHA/ACC Acute PE Clinical Categories (2026)
Adverse Pregnancy Outcomes
Biological Therapies for Atrial Fibrillation
AF-CARE Framework
AF Staging
AI in Cardio-Oncology
AL Amyloidosis — Staging and Risk Stratification
Alcoholic Cardiomyopathy
Amiodarone-Induced Thyroid Disorders
Amiodarone Pulmonary Toxicity
Ankle-Brachial Index (ABI)
Antiarrhythmic Drugs
Aortic Regurgitation
Aortic Stenosis
Arrhythmogenic Cardiomyopathy (ACM)
ARVC Task Force Criteria (2010 Modified)
ASCVD Risk Assessment
Atrial Cardiomyopathy
Atrial Failure
Atrial Myopathy in HCM
Autonomic Dysfunction in Cancer
Balloon Pulmonary Angioplasty (BPA)
Beta-Blocker Therapy After Myocardial Infarction
Bidirectional Ventricular Tachycardia
Biological Pacemaker
Blood Culture–Negative Endocarditis (BCNE)
Brain-Heart Axis
Calcium Homeostasis in HCM
Calmodulinopathy
Complementary and Alternative Medicine in Heart Failure
Cancer-Associated Arrhythmia
Cancer-Associated VTE
Cancer Therapy-Related Cardiovascular Toxicity (CTR-CVT)
Cardiac Action Potential
Cardiac Amyloidosis — Multimodality Imaging
Cardiac Rehabilitation
Cardiac Repolarization
Cardiac Resynchronization Therapy
Cardio-Obstetrics
Cardio-Oncology
Cardiogenetic Centers
Cardiopulmonary Exercise Testing (CPET)
Cardiorenal Syndrome
Cascade Family Screening (ACM & HCM)
Catheter Ablation for Atrial Fibrillation
Calcific Aortic Valve Disease — Molecular Mechanisms
CHA2DS2-VA Score
Circadian Rhythm and Cardiac Electrophysiology
ClinGen Gene-Disease Validity Framework
Clonal Hematopoiesis
Chronic Limb-Threatening Ischemia (CLTI)
Colchicine in Cardiovascular Disease
Conduction Disorders in Young Adults
Conduction System Pacing
Constrictive Pericarditis vs Restrictive Cardiomyopathy
Coronary Microvascular Dysfunction
Coronary Vasospasm
CRISPR-Cas9 in Channelopathies
Cuffless Blood Pressure Monitoring
Danon Disease
DAPT Strategies in ACS and CCD
Desmosome (Cardiac)
Diuretic Resistance
Drug-Induced Arrhythmia
Direct-to-Consumer Genetic Testing (DTC-GT)
Dyslipidemia Management
Early-Onset Atrial Fibrillation
ECG Conduction Disturbances
ECG Lead Standards
ECG Ventricular Hypertrophy
Eisenmenger Syndrome
Electrical Remodeling
Electrical Storm
Epicardial Adipose Tissue Arrhythmogenesis
Epigenetics of Cardiac Arrhythmia
Exercise and Sports Participation in HCM
Exercise Restriction in ARVC
Fabry Cardiomyopathy
Familial Hypercholesterolemia
Final Common Pathway (Cardiomyopathy)
Fontan Circulation — Adult Management
Gene Editing Risk-Benefit Framework
Gene Silencing Therapy
Genetic Testing in Atrial Fibrillation
Genetic Testing in Cardiomyopathy
GLP-1 Receptor Agonists
Gut Microbiome in Heart Failure
GWAS in Cardiac Genetics
Haploinsufficiency
HCM Risk-SCD (and HCM Risk-Kids)
Heart-Healthy Dietary Patterns
Heart Valve Centre
Heteroplasmy
HF-COPD Comorbidity
HFA-ICOS Cardiovascular Toxicity Risk Stratification
His Bundle Pacing
Hormonal Therapy Cardiovascular Risk
Hyperacute T-waves
Hypertensive Disorders of Pregnancy
Incidental Cardiovascular Genetic Variants
Infective Endocarditis
Inter-Atrial Block
Intracoronary Imaging-Guided PCI
Ion Channel Mutations
Ion Channel Remodeling in HCM
iPSC-Derived Cardiomyocytes
Iron Deficiency in Heart Failure
Late Gadolinium Enhancement (LGE)
Left Atrial Strain
Left Bundle Branch Area Pacing
Left Cardiac Sympathetic Denervation
Life's Essential 8
Lipoprotein(a)
Long Noncoding RNA in CVD
LQTS Pregnancy Management
LV Diastolic Function
Left Ventricular Outflow Tract Obstruction (LVOTO)
MEPPC (Multifocal Ectopic Premature Purkinje-Related Complexes)
Mineralocorticoid Receptor Antagonists After Myocardial Infarction
MINOCA
Mitochondrial Cardiomyopathy
Mitral Stenosis
Modifier Genes
Multivessel PCI Timing in STEMI
Modified WHO Classification of Maternal Cardiovascular Risk
Myocardial Viability
Noncoding RNA in Cardiovascular Disease
NSTEMI Invasive Strategy in Elderly Patients
Obesity Paradox
OMI/NOMI Paradigm
OSA Arrhythmogenic Substrate
PAD Exercise Therapy
PAD Medical Therapy
PAH Risk Stratification
Perioperative Cardiovascular Assessment
Periprocedural CIED Management
Pharmacogenomics in Heart Failure
Pharmacological Provocation Testing
Phenotypic Approach to Cardiomyopathy
Polygenic Risk Score
Pompe Disease
Potassium and Ventricular Arrhythmias
Precision Medicine in LQTS
Preeclampsia
Prepregnancy Cardiovascular Health
Primary Mitral Regurgitation
Pulmonary Hypertension Classification
Pulmonary Hypertension
Pulsed-Field Ablation
PVC-Induced Cardiomyopathy
PVC Mapping and Ablation
Q-Wave Remodeling
Radiation Vasculopathy
Remote Patient Monitoring in Cardiovascular Medicine
Renal Denervation
Right Heart Catheterization
Right Ventricular Failure
RV–PA Coupling
Sarcomere Biology
Schwartz Score
Secondary Mitral Regurgitation
Septal Reduction Therapy (SRT)
Sex Differences in Channelopathies
Sgarbossa Criteria
SGLT2 Inhibitors in Chronic Kidney Disease
Shanghai Score System
Sleep-Disordered Breathing
Sports Cardiology and Shared Decision-Making
ST-T Changes
Structural Valve Deterioration
Subclinical Atrial Fibrillation (SCAF)
Sudden Cardiac Death
Suppression-and-Replacement (SupRep) Therapy
TAVI (Transcatheter Aortic Valve Implantation)
Tetralogy of Fallot (Repaired) — Adult Management
Titin Isoform Switch
Titin Post-Translational Modifications (PTMs)
Torsades de Pointes
Tricuspid Regurgitation
TTR Stabilizer Therapy
VA Risk Stratification in Dilated Cardiomyopathy
Valvular Heart Disease
Genetic Variant Reclassification in Cardiovascular Disease
Visceral Adiposity and Ectopic Fat
VT Ablation in Ischemic Cardiomyopathy
Wellens Syndrome
entities
Acute Coronary Syndrome
Aficamten
AL (Light Chain) Amyloidosis
Arrhythmogenic Left Ventricular Cardiomyopathy (ALVC)
Amiodarone
Andersen-Tawil Syndrome (LQT7)
Anderson-Fabry Disease (AFD)
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Atrial Fibrillation
Atrial Flutter
Transthyretin Amyloidosis (ATTR)
Bicuspid Aortic Valve
Brugada Syndrome
CASQ2
Cardiac Contractility Modulation (CCM)
Chronic Coronary Disease
Chronic Obstructive Pulmonary Disease (COPD)
CORIN
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Cardiac Resynchronization Therapy (CRT)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Dilated Cardiomyopathy (DCM)
DES (Desmin)
Dronedarone
DSC2 (Desmocollin-2)
DSG2 (Desmoglein-2)
DSP (Desmoplakin)
Early Repolarization Syndrome
Fabry Disease
Finerenone (Kerendia)
Flecainide
FLNC (Filamin-C)
Frailty in Cardiovascular Disease
Hypertrophic Cardiomyopathy (HCM)
Heart Failure
Heart Failure with Preserved Ejection Fraction (HFpEF)
HFrEF — Heart Failure with Reduced Ejection Fraction
Hypertension
Implantable Cardioverter-Defibrillator (ICD)
Idiopathic Ventricular Fibrillation
Ischemic Stroke
JUP (Plakoglobin) — Naxos Disease
KCNH2 (hERG)
KCNJ2 (Kir2.1)
KCNQ1
Left Atrial Appendage Occlusion (LAAO)
Left Main Coronary Disease
LMNA (Lamin A/C)
Long QT Syndrome
MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)
Maternal Health Disparities
Mavacamten
Mitral Valve Prolapse
MYBPC3 (Cardiac Myosin Binding Protein C)
MYH6 (Alpha-Myosin Heavy Chain)
MYH7 (Beta-Myosin Heavy Chain)
Non-Dilated Left Ventricular Cardiomyopathy (NDLVC)
Nexiguran Ziclumeran (Nex-z / NTLA-2001)
NOS1AP
Obesity
Obstructive Sleep Apnea
Omecamtiv Mecarbil
Patisiran
Peripartum Cardiomyopathy
Peripheral Artery Disease
PKP2 (Plakophilin-2)
PLN (Phospholamban)
PMCardio Queen of Hearts
PRKAG2 Cardiac Syndrome
Pulmonary Embolism
Pulmonary Hypertension
Restrictive Cardiomyopathy (RCM)
Rheumatic Heart Disease
RYR2
Subcutaneous ICD (S-ICD)
Sacubitril–Valsartan (ARNI)
SCN5A
Semaglutide
Short QT Syndrome
Sotatercept
Takotsubo Cardiomyopathy
Tirzepatide
TMEM43
TTN (Titin)
Vericiguat
Vutrisiran (AMVUTTRA)
sources
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
AAV9-Mediated Gene Therapy for Infantile-Onset Pompe's Disease
AAV-mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload (ADVOR)
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM)
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
2024 ESC Guidelines for the Management of Atrial Fibrillation
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (MAPLE-HCM)
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM)
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
Amiodarone: A Comprehensive Guide for Clinicians
Amiodarone Pulmonary Toxicity
Amiodarone: Review of Pulmonary Effects and Toxicity
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (ARTESIA)
PARADIGM-HF: Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology
Importance of Diastolic Function for the Prediction of Arrhythmic Death (Pezawas et al.)
Cardiac arrhythmias and genetics – current stage
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC
Beta-Blocker Interruption or Continuation after Myocardial Infarction — ABYSS Trial
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (REDUCE-AMI)
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction (SMART-DECISION)
Blood Culture–Negative Endocarditis: A Scientific Statement From the American Heart Association
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
Systematic Review of Biological Therapies for Atrial Fibrillation
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Brugada Syndrome (State-of-the-Art Review)
Catheter Ablation for Atrial Fibrillation: Indications and Future Perspective
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation (CASTLE-HTx)
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes
Core Components of Cardiac Rehabilitation Programs: 2024 Update
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
2022 ESC Guidelines on Cardio-Oncology
Cardio-Oncology: Vascular and Metabolic Perspectives — AHA Scientific Statement 2019
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies — AHA Scientific Statement 2019
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism (HI-PEITHO)
Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics
Circadian Influences on Sudden Cardiac Death and Cardiac Electrophysiology
ClinGen Curation Activity Summary Report 2026-05-09
Colchicine in Acute Myocardial Infarction (CLEAR Trial)
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction (MULTISTARS AMI)
Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF)
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT Long-Term)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events (MADIT-CRT)
EHRA Clinical Consensus Statement on Conduction System Pacing Implantation (2023)
Cardiac Conduction System Pacing: A Comprehensive Update
Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association
Cardiovascular Considerations in Caring for Pregnant Patients
2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
Dilated Cardiomyopathy and Precision Medicine — Heart Failure Reviews 2022
2026 AHA Dietary Guidance to Improve Cardiovascular Health
Digitoxin in Heart Failure with Reduced Ejection Fraction (DIGIT-HF) — Bavendiek, Bauersachs et al., NEJM 2025
Dronedarone
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III: Intraventricular Conduction Disturbances
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part VI: Acute Ischemia/Infarction
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ECG — Part IV: The ST Segment, T and U Waves, and the QT Interval
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology
Recommendations for the Evaluation of LV Diastolic Function by Echocardiography and for HFpEF Diagnosis: An Update from the ASE (2025)
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes (NOAH-AFNET 6)
Empagliflozin after Acute Myocardial Infarction (EMPACT-MI)
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY Post-Trial)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction (EMPEROR-Preserved)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced)
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
Early-onset atrial fibrillation without structural heart disease: lifestyle and hereditary risk factors
Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue
2023 ESC Guidelines for the Management of Cardiomyopathies
Anderson–Fabry Disease Management: Role of the Cardiologist
Fabry Disease Cardiomyopathy: A State-of-the-Art Review
Failure of standard contemporary STEMI ECG criteria to identify acute LAD occlusion
Ferric Carboxymaltose in Heart Failure with Iron Deficiency (HEART-FID)
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF)
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Gene editing for inherited cardiac conditions: A new frontier in cardiology
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications
Clinical Genetic Testing for Atrial Fibrillation: Are We There Yet?
Genetically based atrial fibrillation: Current considerations for diagnosis and management
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Genetic testing in early-onset atrial fibrillation
Genetic Testing for Inherited Cardiovascular Diseases — AHA Scientific Statement 2020
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease
Actionable Genotypes and Their Association with Life Span in Iceland
The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies
Hyperacute T Waves Are Specific for Occlusion Myocardial Infarction, Even Without Diagnostic ST-Segment Elevation
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association
2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System
2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
ACC/AHA/HRS 2025 Appropriate Use Criteria for ICD, CRT, and Pacing
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure (SCD-HeFT) — Bardy et al., NEJM 2005
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure (DANISH Trial)
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy (DEFINITE)
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal ICD Programming and Testing
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 2
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 1
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association
State of the Art: Imaging for Myocardial Viability — AHA Scientific Statement
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association
The Inherited Basis of Coronary Artery Disease
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI
IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation (CHAMPION-AF)
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE-AF)
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation (OPTION Trial)
Systemic Light Chain Amyloidosis
2026 ACC/AHA Guideline on the Management of Dyslipidemia
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for ASCVD — AHA Scientific Statement 2021
Congenital Long QT Syndrome
Long QT Syndrome
Long QT Syndrome Management during and after Pregnancy
Metabolic Dysfunction–Associated Steatotic Liver Disease
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM)
Cardiac Transmembrane Ion Channels and Action Potentials: Cellular Physiology and Arrhythmogenic Behavior
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association
Modifier Genes for Sudden Cardiac Death
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure (RALES) — Pitt et al., NEJM 1999
Cardiac Myosin-Binding Protein C (MYBPC3) in Cardiac Pathophysiology
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3 and MYH7-Mediated Hypertrophic Cardiomyopathy
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure (GALACTIC-HF)
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (SOUL)
Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis (APOLLO-B)
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
REVIVED-BCIS2: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association
Peripartum Cardiomyopathy
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation (ADVENT)
Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation — SINGLE SHOT CHAMPION
The Diagnostic Role of Pharmacological Provocation Testing in Cardiac Electrophysiology — EHRA Consensus 2025
2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Multidomain Rehabilitation for Older Patients with Myocardial Infarction (PIpELINe)
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (POTCAST)
Precision therapy in congenital long QT syndrome
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association
Mapping and Ablation of Premature Ventricular Complexes
2024 ACC/AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease
Electrocardiographic Q-Wave 'Remodeling' in Reperfused ST-Segment Elevation Myocardial Infarction: Validation Study With CMR
Cardiac Repolarization in Health and Disease
Right heart catheterization in heart failure: indications, interpretation, and pitfalls
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
Right Ventricular Failure
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications — AHA Scientific Statement
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (STEP-HFpEF)
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis (HYPERION)
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death (ZENITH)
Routine Spironolactone in Acute Myocardial Infarction — CLEAR (NEJM 2025)
Spironolactone for Heart Failure with Preserved Ejection Fraction (TOPCAT)
Electrophysiological Mechanisms of ST Segment and T‑Wave Changes: Insights into Ischemia, Conduction Delay, Hypertrophy, and Electrolyte Disturbance
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap — AHA Scientific Statement 2019
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3)
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Tricuspid Regurgitation (NEJM 2023)
Titin (TTN): from molecule to modifications, mechanics, and medical significance
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association
Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction (VICTORIA)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia (VANISH2)
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (HELIOS-B)
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
Source Index
Wiki Index
Arrhythmia index
Cardiomyopathy index
Genetics index
Cardiology Wiki Master Index
Enter your search text in the box above
Select a result to preview
Cardiology Wiki (Genetics)
Overview
LQTS/SQTS
ClinGEN
clingen-summary-2026-05-09
KCNQ1
KCNQ1
Genetic test in CMP
concepts/Genetic-Testing-in-Cardiomyopathy
KCNH2
KCNH2
Genetic test in AF
concepts/Genetic-Testing-in-AF
CALM
Calmodulinopathy
DTC genetic testing
DTC-Genetic-Testing
Brugada
GWAS
GWAS-Cardiac-Genetics
SCN5A
SCN5A
Channelopathy
CPVT
LQTS
entities/Long-QT-Syndrome
RYR2
RYR2
SQTS
entities/Short-QT-Syndrome
CASQ2
CASQ2
Brugada Syndrome
entities/Brugada-Syndrome
ERS
entities/Early-Repolarization-Syndrome
HCM
CPVT
entities/CPVT
MYBPC3
MYBPC3
IVF
entities/Idiopathic-Ventricular-Fibrillation
MYH7
MYH7
PLN
PLN
Cardiomyopathies
ARVC
ARVC
DCM
ACM
Arrhythmogenic-Cardiomyopathy
TTN
TTN
HCM
HCM
LMNA
LMNA
DCM
DCM
FLNC
FLNC
DES
DES
Management
HCM SCD risk
HCM-Risk-SCD
ARVC
DCM SCD risk
VA-Risk-Stratification-DCM
PKP2
PKP2
LQTS Pregnancy
LQTS-Pregnancy-Management
DSC2
DSC2
Cascade Family screening
Cascade-Family-Screening
DSG2
DSG2
Gene Silencing Therapy
Gene-Silencing-Therapy
DSP
DSP
AAV Gene Delivery
AAV-Gene-Delivery
TMEM43
TMEM43
SupRep Therapy
SupRep-Therapy